These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 27392263)

  • 41. Non-alcoholic fatty liver disease in diabetics--prevalence and predictive factors in a multiracial hospital clinic population in Malaysia.
    Chan WK; Tan AT; Vethakkan SR; Tah PC; Vijayananthan A; Goh KL
    J Gastroenterol Hepatol; 2013 Aug; 28(8):1375-83. PubMed ID: 23517307
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serum alanine aminotransferase predicts interventricular septum thickness and left ventricular mass in patients with nonalcoholic fatty liver disease.
    Ybarra J; Fernández S; Sánchez-Hernández J; Romeo JH; Ballesta-Lopez C; Guell J; Mearin F
    Eur J Gastroenterol Hepatol; 2014 Jun; 26(6):654-60. PubMed ID: 24667349
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Influence of light alcohol consumption on lifestyle-related diseases: a predictor of fatty liver with liver enzyme elevation in Japanese females with metabolic syndrome.
    Sogabe M; Okahisa T; Nakagawa T; Fukuno H; Nakasono M; Tomonari T; Tanaka T; Tanaka H; Taniguchi T; Muguruma N; Takayama T
    BMC Gastroenterol; 2016 Feb; 16():17. PubMed ID: 26892109
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The alanine aminotransferase to triglycerides ratio as a marker to identify nonalcoholic fatty liver disease.
    Simental-Mendía LE; Rodríguez-Hernández H; Rodríguez-Morán M; Guerrero-Romero F
    Eur J Gastroenterol Hepatol; 2012 Oct; 24(10):1173-7. PubMed ID: 22735606
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Relationships Between Alanine Aminotransferase, Serum Triglycerides, Body Mass Index and Nonalcoholic Fatty Liver Disease in an Outpatient Pediatric Clinic Population.
    Cohen D; Gonzales-Pacheco D; Myers O
    J Pediatr Nurs; 2016; 31(2):152-8. PubMed ID: 26690717
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prevalence and etiology of elevated serum alanine aminotransferase level in an adult population in Taiwan.
    Chen CH; Huang MH; Yang JC; Nien CK; Yang CC; Yeh YH; Yueh SK
    J Gastroenterol Hepatol; 2007 Sep; 22(9):1482-9. PubMed ID: 17716352
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serum Bile Acid Levels in Children With Nonalcoholic Fatty Liver Disease.
    Jahnel J; Zöhrer E; Alisi A; Ferrari F; Ceccarelli S; De Vito R; Scharnagl H; Stojakovic T; Fauler G; Trauner M; Nobili V
    J Pediatr Gastroenterol Nutr; 2015 Jul; 61(1):85-90. PubMed ID: 25729888
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prevalence of and predictive factors for nonalcoholic fatty liver disease in Sudanese individuals with type 2 diabetes: Is metabolic syndrome the culprit?
    Almobarak AO; Barakat S; Suliman EA; Elmadhoun WM; Mohamed NA; Abobaker IO; Noor SK; Bushara SO; Ahmed MH
    Arab J Gastroenterol; 2015 Jun; 16(2):54-8. PubMed ID: 26174761
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Association Between Urinary Alpha1-Microglobulin Levels and Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study.
    Zhang J; Zhang X; Zhao Y; Lv G
    Ann Nutr Metab; 2018; 72(1):30-36. PubMed ID: 29232673
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The value of different insulin resistance indices in assessment of non-alcoholic fatty liver disease in overweight/obese children.
    El-Karaksy HM; El-Raziky MS; Fouad HM; Anwar GM; El-Mougy FM; El-Koofy NM; El-Hennawy AM
    Diabetes Metab Syndr; 2015; 9(2):114-9. PubMed ID: 25470627
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Increased prevalence of polycystic ovary syndrome in premenopausal women with nonalcoholic fatty liver disease.
    Vassilatou E; Vassiliadi DA; Salambasis K; Lazaridou H; Koutsomitopoulos N; Kelekis N; Kassanos D; Hadjidakis D; Dimitriadis G
    Eur J Endocrinol; 2015 Dec; 173(6):739-47. PubMed ID: 26340970
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The role of liver fat and insulin resistance as determinants of plasma aminotransferase elevation in nonalcoholic fatty liver disease.
    Maximos M; Bril F; Portillo Sanchez P; Lomonaco R; Orsak B; Biernacki D; Suman A; Weber M; Cusi K
    Hepatology; 2015 Jan; 61(1):153-60. PubMed ID: 25145475
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Subclinical and clinical hypothyroidism and non-alcoholic fatty liver disease: a cross-sectional study of a random population sample aged 18 to 65 years.
    Ludwig U; Holzner D; Denzer C; Greinert A; Haenle MM; Oeztuerk S; Koenig W; Boehm BO; Mason RA; Kratzer W; Graeter T;
    BMC Endocr Disord; 2015 Aug; 15():41. PubMed ID: 26276551
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Blood lead level is associated with non-alcoholic fatty liver disease in the Yangtze River Delta region of China in the context of rapid urbanization.
    Zhai H; Chen C; Wang N; Chen Y; Nie X; Han B; Li Q; Xia F; Lu Y
    Environ Health; 2017 Aug; 16(1):93. PubMed ID: 28859656
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of effects of obesity and non-alcoholic fatty liver disease on incidence of type 2 diabetes mellitus.
    Li WD; Fu KF; Li GM; Lian YS; Ren AM; Chen YJ; Xia JR
    World J Gastroenterol; 2015 Aug; 21(32):9607-13. PubMed ID: 26327768
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Prevalence of Elevated Alanine Aminotransferase Levels Meeting Clinical Action Thresholds in Children with Obesity in Primary Care Practice.
    Wu SJ; Darbinian JA; Schwimmer JB; Yu EL; Ramalingam ND; Greenspan LC; Lo JC
    J Pediatr; 2022 Jan; 240():280-283. PubMed ID: 34562443
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Non-alcoholic fatty liver disease prevalence among school-aged children and adolescents in Iran and its association with biochemical and anthropometric measures.
    Alavian SM; Mohammad-Alizadeh AH; Esna-Ashari F; Ardalan G; Hajarizadeh B
    Liver Int; 2009 Feb; 29(2):159-63. PubMed ID: 18492015
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A decrease in fasting FGF19 levels is associated with the development of non-alcoholic fatty liver disease in obese adolescents.
    Wojcik M; Janus D; Dolezal-Oltarzewska K; Kalicka-Kasperczyk A; Poplawska K; Drozdz D; Sztefko K; Starzyk JB
    J Pediatr Endocrinol Metab; 2012; 25(11-12):1089-93. PubMed ID: 23329754
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Type 1 Diabetes and Non-Alcoholic Fatty Liver Disease: When Should We Be Concerned? A Nationwide Study in Brazil.
    Barros BSV; Santos DC; Pizarro MH; del Melo LGN; Gomes MB
    Nutrients; 2017 Aug; 9(8):. PubMed ID: 28809804
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Omega-3 Fatty acids therapy in children with nonalcoholic Fatty liver disease: a randomized controlled trial.
    Janczyk W; Lebensztejn D; Wierzbicka-Rucińska A; Mazur A; Neuhoff-Murawska J; Matusik P; Socha P
    J Pediatr; 2015 Jun; 166(6):1358-63.e1-3. PubMed ID: 25771388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.